Only logged in customers who have purchased this product may leave a review.

Adamax
- Research Grade
- 99% Purity
- Third-Party Verified
Adamax
Adamax is an adamantane-modified analogue of Semax (N-acetyl Semax Amidate) investigated for its potential nootropic, neuroprotective and cognitive-supporting properties.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About Adamax
Adamax is derived from the ACTH(4–10) analogue Semax. The adamantane modification is intended to improve peptide stability and blood–brain barrier penetration compared with standard Semax.
How It Works in Research
Adamax is structurally derived from Semax. Preclinical studies suggest Semax-class peptides may increase BDNF signalling, enhance TrkB receptor activity, influence dopamine and serotonin pathways, and promote neuroplasticity. The adamantane modification is intended to improve lipophilicity, stability and blood–brain barrier penetration.
Research Applications
• Cognitive function • Memory • Neuroplasticity • Neuroprotection • Mood support • Stress resilience
Product Specifications
- Product Name: Adamax
- Reference Strength: 5 mg
- Appearance: White to off-white lyophilised powder
- Purity Standard: ≥98% (HPLC)
Research Information
- Category: Nootropic peptide
- Reconstitution: 1.5 mL bacteriostatic water
- Final Concentration: 3.33 mg/mL
- Storage: 2–8°C after reconstitution
Mechanism of Action
Adamax is structurally derived from Semax. Preclinical studies suggest Semax-class peptides may increase BDNF signalling, enhance TrkB receptor activity, influence dopamine and serotonin pathways, and promote neuroplasticity. The adamantane modification is intended to improve lipophilicity, stability and blood–brain barrier penetration.
Potential Benefits in Research
Research has explored potential support for learning, memory, neuroprotection, mood regulation and neuronal resilience. Human data specific to Adamax remain limited.
Research Applications
REFERENCE RECONSTITUTION INFORMATION
Goal: Support cognitive enhancement, neuroprotection and neuroplasticity. Schedule: Daily subcutaneous injections for 8–12 weeks (optional extension to 16 weeks), followed by an equal off-cycle period. Dose Range: 0.3–1.0 mg daily with gradual titration. Reconstitution: Add 1.5 mL bacteriostatic water to one 5 mg vial (3.33 mg/mL).
Always follow sterile preparation techniques when handling research peptides.
General Preparation
- Reconstitute: Add 1.5 mL bacteriostatic water → ~3.33 mg/mL.
- Typical daily range: 0.5–1.0 mg once daily.
- Easy measuring: 1 unit = 0.01 mL ≈ 0.0333 mg on a U-100 insulin syringe.
- Storage: Lyophilized: −20°C; after reconstitution refrigerate at 2–8°C and use within 4–5 weeks.
ADAMAX (5MG)- RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of Adamax.
- Adamax is dosed at 0.3–1.0 mg daily via subcutaneous injection in educational protocols.
Reference Parameters (Dosing Protocol)
| Week | Daily Dose (mg) | U-100 Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.3 mg | 9 units | 0.09 mL |
| Weeks 3–4 | 0.5 mg | 15 units | 0.15 mL |
| Weeks 5–6 | 0.75 mg | 23 units | 0.23 mL |
| Weeks 7–8 | 1.0 mg | 30 units | 0.30 mL |
Experimental Study Period
View Certificate of Analysis
View Certificate of Analysis Each batch of Adamax is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.

Reviews
There are no reviews yet.